Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $550.9700 (1.84%) ($537.9486 - $556.3100) on Thu. Sep. 17, 2015. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.35% (three month average) | RSI | 53 | Latest Price | $550.9700(1.84%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 0.7% a day on average for past five trading days. | Weekly Trend | REGN advances 2% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(65%) XLV(53%) XBI(50%) QQQ(42%) IWF(41%) | Factors Impacting REGN price | REGN will decline at least -1.175% in a week (0% probabilities). VIXM(-15%) TLT(-9%) UUP(-6%) SHY(-4%) TIP(-2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.175% (StdDev 2.35%) | Hourly BBV | 0 () | Intraday Trend | 2.4% | | | |
|
5 Day Moving Average | $539.62(2.1%) | 10 Day Moving Average | $531.54(3.66%) | 20 Day Moving Average | $526.57(4.63%) | To recent high | -7% | To recent low | 11% | Market Cap | $58.419b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |